Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Jul 25;13(7):1463–1480. doi: 10.21037/tlcr-24-215

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

2024 Translational Lung Cancer Research. All rights reserved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0.

PMC Copyright notice

Comparison of post-resection survival outcomes based on PD-L1 expression, analyzed using different assays. (A) Comparison of post-resection PFS between patients with no PD-L1 expression and those with PD-L1 expression, analyzed using the SP263 assay. (B) Comparison of post-resection OS in patients with no PD-L1 expression vs. those with PD-L1 expression, analyzed using the SP263 assay. (C) Analysis of post-resection PFS in patients with no PD-L1 expression compared to those with PD-L1 expression, based on the 22C3 assay. (D) Assessment of post-resection OS in patients with no PD-L1 expression vs. those with PD-L1 expression, based on the 22C3 assay. PD-L1, programmed death-ligand 1; PFS, progression-free survival; OS, overall survival.